Skip to main content
Clinical Trials/NL-OMON50917
NL-OMON50917
Recruiting
Not Applicable

DIAGNOSTIC ARTHROSCOPY VERSUS ARTHROCENTESIS AS INITIAL TREATMENT FOR ARTHRALGIA OF THE TEMPOROMANDIBULAR JOINT A mono-center single-blind randomized controlled trial - DIAMOND trial

niversitair Medisch Centrum Groningen0 sites140 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Degeneration of the jaw joint
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
140
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients aged 18 years or older.
  • \- Arthralgia of the Temporomandibular joint (TMJ), proven with a diagnostic
  • intra\-articular injection with Ultracain DS Forte.
  • \- TMJ pain still present after two weeks of NSAIDs
  • \- Symptoms presenting unilaterally or bilaterally with at least one TMJ with a
  • Visual Analog Scale\-score \< 30 mm during movement or function, after
  • anesthetizing the contralateral joint.

Exclusion Criteria

  • \- Systemic rheumatic disease
  • \- Bony ankylosis of the Temporomandibular Joint (TMJ)
  • \- Congenital or acquired dentofacial deformity
  • \- History of jaw trauma that resulted in jaw or joint pain, bony changes or
  • mandibular growth restriction
  • \- Prior arthrocentesis, (diagnostic) arthroscopy or open\-TMJ surgery
  • \- Psychiatric disorder (as diagnosed by a physician)
  • \- Unwillingness to receive one of the study treatments
  • \- Pregnancy at time of treatment
  • \- Concurrent use of steroids, muscle relaxants or anti\-inflammatory drugs other

Outcomes

Primary Outcomes

Not specified

Similar Trials